Basics Neuronetics, Inc. Common Stock IPO Date: June 25, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $261.31M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.80% Avg Daily Range (30 D): $0.13 | 3.17% Avg Daily Range (90 D): $0.19 | 4.94% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): .74M Avg Daily Volume (90 D): 1.2M Trade Size Avg Trade Size (Sh.): 153 Avg Trade Size (Sh.) (30 D): 127 Avg Trade Size (Sh.) (90 D): 153 Institutional Trades Total Inst.Trades: 147 Avg Inst. Trade: $1.86M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $.91M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.51M Avg Closing Trade (30 D): $1.47M Avg Closing Trade (90 D): $1.47M Avg Closing Volume: 384.17K         News Dec 10, 2024 @ 3:00 PM Neuronetics and Greenbrook TMS Announce Closing of... Source: N/A Jul 2, 2024 @ 2:40 PM Neuronetics (STIM) Expands NeuroStar Portfolio Wit... Source: Zacks Equity Research Jul 1, 2024 @ 12:02 PM NeuroStar® Launches Better Me Provider Program ... Source: Neuronetics Jun 13, 2024 @ 12:31 PM NeuroStar Showcases Cutting-Edge Research at Clini... Source: Neuronetics May 23, 2024 @ 12:30 PM Neuronetics to Present at the William Blair 44th A... Source: Neuronetics Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.32 $-.21 $-.34 Diluted EPS $-1.32 $-.21 $-.34 Revenue $ 89.45M $ 31.98M $ 22.49M Gross Profit $ 56.81M $ 15.74M $ 14.89M Net Income / Loss $ -48.54M $ -12.69M $ -12.68M Operating Income / Loss $ -38.72M $ -11.01M $ -11.47M Cost of Revenue $ 32.64M $ 16.24M $ 7.6M Net Cash Flow $ -29.24M $ 1.77M $ -1.41M PE Ratio